@Article{CHD.2021.016713,
AUTHOR = {Gabriele Egidy Assenza, Biagio Castaldi, Serena Flocco, Giovanni Battista Luciani, Giovanni Meliota, Gabriele Rinelli, Ugo Vairo, Silvia Favilli, Board of the Italian Society of Pediatric Cardiology},
TITLE = {COVID-19 Vaccine Priority Access for Adults and Children with Congenital Heart Disease: A Statement of the Italian Society of Pediatric Cardiology},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {16},
YEAR = {2021},
NUMBER = {5},
PAGES = {427--431},
URL = {http://www.techscience.com/schd/v16n5/42679},
ISSN = {3071-1738},
ABSTRACT = {COVID-19 pandemic continues to strike across the world with increasing number of infected patients, severe
morbidity and mortality, social life and economy disruption. Universal access to vaccine prophylaxis will be pivotal in controlling this infection and providing individual level protection. However, mismatch between vaccine
request and vaccine availability, as well as constraints in logistics of vaccine campaign is creating a transition
phase of progressive but still incomplete inclusion of group of individuals in the vaccination process. Selected
patients living with chronic and multisystemic disease may present increased propensity of adverse outcome,
should Sars-Cov-2 infection develop. In these patients, expedite access to COVID-19 vaccination may be considered. The Italian Society of Pediatric Cardiology National Board is providing a viewpoint to inform policy makers
and public authorities during vaccine allocation strategies development, to consider higher priority and expedite
access for selected groups of patients living with congenital heart disease.},
DOI = {10.32604/CHD.2021.016713}
}